For example, studies in PD families as well as in sporadic PD cases suggest an SNCA gene-dosage effect critical to disease pathogenesis, but there is also indication of upregulated SNCA gene expression resulting from promoter demethylation in PD brains [72, 73]. The gene discussed is SNCA; the disease is Parkinson disease.